{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["147"],"submitter":["Guarneri V"],"funding":["Fondazione Cassa di Risparmio di Padova e Rovigo"],"pubmed_abstract":["<h4>Introduction</h4>Coronavirus disease 2019 (COVID-19) pandemic started in Italy with clusters identified in Northern Italy. The Veneto Oncology Network (Rete Oncologica Veneta) licenced dedicated guidelines to ensure proper care minimising the risk of infection in patients with cancer. Rete Oncologica Veneta covID19 (ROVID) is a regional registry aimed at describing epidemiology and clinical course of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cancer.<h4>Materials and methods</h4>Patients with cancer diagnosis and documented SARS-CoV-2 infection are eligible. Data on cancer diagnosis, comorbidities, anticancer treatments, as well as details on SARS-CoV-2 infection (hospitalisation, treatments, fate of the infection), have been recorded. Logis"],"journal":["European journal of cancer (Oxford, England : 1990)"],"pagination":["120-127"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7857033"],"repository":["biostudies-literature"],"pubmed_title":["Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study."],"pmcid":["PMC7857033"],"pubmed_authors":["Veneto Oncology Network","Toso S","Favaretto A","Ziampiri S","Azzarello G","Di Liso E","Chiarion-Sileni V","Gori S","Aprile G","Pastorelli D","Puccetti O","Zustovich F","Morandi P","Guarneri V","Zaninelli M","Zagonel V","Mandara M","Zampiva I","Cattelan AM","Bassan F","Celestino M","Bernardi D","Oliani C","Chiari R","Conte P","Vianello A","Milella M","Scola A","Dieci MV","Caccese M"],"additional_accession":[]},"is_claimable":false,"name":"Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.","description":"<h4>Introduction</h4>Coronavirus disease 2019 (COVID-19) pandemic started in Italy with clusters identified in Northern Italy. The Veneto Oncology Network (Rete Oncologica Veneta) licenced dedicated guidelines to ensure proper care minimising the risk of infection in patients with cancer. Rete Oncologica Veneta covID19 (ROVID) is a regional registry aimed at describing epidemiology and clinical course of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cancer.<h4>Materials and methods</h4>Patients with cancer diagnosis and documented SARS-CoV-2 infection are eligible. Data on cancer diagnosis, comorbidities, anticancer treatments, as well as details on SARS-CoV-2 infection (hospitalisation, treatments, fate of the infection), have been recorded. Logis","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Apr","modification":"2025-05-31T23:33:31.817Z","creation":"2025-05-31T23:33:31.817Z"},"accession":"S-EPMC7857033","cross_references":{"pubmed":["33647547"],"doi":["10.1016/j.ejca.2021.01.021"]}}